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Abstract
!
Aims: The aim was to establish an official inter-
disciplinary guideline, published and coordinated
by the German Society of Gynecology and Obstet-
rics (DGGG). The guideline was developed for use
in German-speaking countries. In addition to the
Germany Society of Gynecology and Obstetrics,
the guideline has also been approved by the Swiss
Society of Gynecology and Obstetrics (SGGG) and
the Austrian Society of Gynecology and Obstetrics
(OEGGG). This is a guideline published and coor-
dinated by the DGGG. The aim is to provide evi-
dence-based recommendations obtained by eval-
uating the relevant literature for the diagnostic,
conservative and surgical treatment of women
with female pelvic organ prolapse with or with-
out stress incontinence.
Methods: We conducted a systematic review to-
gether with a synthesis of data and meta-analy-
ses, where feasible. MEDLINE, Embase, Cinahl, Pe-
dro and the Cochrane Register were searched for
relevant articles. Reference lists were hand-
searched, as were the abstracts of the Annual
Meetings of the International Continence Society
and the International Urogynecological Associa-
tion. We included only abstracts of randomized
controlled trials that were presented and dis-
cussed in podium sessions. We assessed original
data on surgical procedures published since 2008
with a minimum follow-up time of at least 12
months. If the studies included descriptions of
perioperative complications, this minimum fol-
low-up period did not apply.
Recommendations: The guideline encompasses
recommendations for the diagnosis and treat-
ment of female pelvic organ prolapse. Recom-
mendations for anterior, posterior and apical pel-
vic organ prolapse with or without concomitant
stress urinary incontinence, uterine preservation
options, and the pros and cons of mesh
placements during surgery for pelvic organ pro-
Zusammenfassung
!
Ziel: Erstellung einer offiziellen, internationalen,
interdisziplinären Leitlinie, publiziert und koor-
diniert von der Deutschen Gesellschaft für Gynä-
kologie und Geburtshilfe (DGGG). Die Leitlinie
wurde für den deutschsprachigen Raum ent-
wickelt und wird neben der DGGG auch von der
Schweizerischen Gesellschaft für Gynäkologie
und Geburtshilfe (SGGG) und der Österrei-
chischen Gesellschaft für Gynäkologie und Ge-
burtshilfe (OEGGG) mitgetragen. Das Ziel dieser
Leitlinie, die von der DGGG publiziert und koor-
diniert wurde, ist es, durch die Evaluation der re-
levanten Literatur einen evidenzbasierten Über-
blick über die Diagnostik sowie konservative und
operative Therapie des Descensus genitalis der
Frau mit oder ohne Belastungsinkontinenz zu ge-
ben.
Methoden: Es erfolgte ein systematischer Review
sowie Synthese von Daten, anteilig mit Metaana-
lyse (S2e). Es wurde eine umfassende Literatur-
suche in MEDLINE, Embase, Cinahl, Pedro und im
Cochrane-Register, in Referenzlisten und in den
Abstracts der Annual Meetings der International
Continence Society und der International Uro-
gynecological Association durchgeführt. Ab-
stracts wurden eingeschlossen, wenn es sich um
randomisierte Studien handelte, die als Podi-
umpräsentation vorgestellt und diskutiert wur-
den. Es wurden Originalarbeiten seit 2008 einge-
schlossen, deren Nachkontrollzeitraum bei min-
destens 12 Monaten lag. Für die Beschreibung
von perioperativen Komplikationen wurden jeg-
liche Daten herangezogen.
Empfehlungen: Es werden Empfehlungen zur
Diagnostik, konservativen und operativen Thera-
pie des Genitaldeszensus gegeben, wobei die 3
urogynäkologischen Kompartimente, Prävention
oder Behandlung von Belastungsinkontinenz,
Vor- und Nachteile von Netzaugmentationen so-
wie uteruserhaltende Optionen, berücksichtigt
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lapse are presented. The recommendations are based on an ex-
tensive and systematic review and evaluation of the current liter-
ature and include the experiences and specific conditions in Ger-
many, Austria and Switzerland.
wurden. Sie beruhen auf einer umfassenden, systematischen und
aktuellen Literaturbetrachtung und ‑auswertung unter Berück-
sichtigung von Erfahrungen und spezifischen Bedingungen in
Deutschland, Österreich und der Schweiz.
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Abbreviations
CI Confidence interval
ICI International Consultation on Incontinence
ICS International Continence Society
IUGA International Urogynecological Association
OAB Overactive bladder
OR Odds ratio
POPQ Pelvic organ prolapse quantification system
QOL Quality of life
RCT Randomized controlled trial
RR Relative risk
TVT Tension-free vaginal tapeII Application of the Guideline
Purpose and objectives
The aim of this guideline is to provide an evidence-based over-
view of the diagnosis and the conservative and surgical therapy
of female pelvic organ prolapse and to offer support for targeted
decision-making as part of individual patient care.
The recommendations are based on an extensive, systematic re-
view and evaluation of the current literature and also take the ex-
periences and specific conditions in Germany, Austria and Switz-
erland into account. This represents an update of the guidelines
of 2008 and also includes the warnings issued by the American
Food and Drug Administration (FDA) in its recent notification of
2011 (http://www.fda.gov/medicaldevices/safety/alertsandno-
tices/publichealthnotifications/ucm061976.htm), which resulted
in considerable changes to pelvic surgery and the placement of
surgical meshes. But of course, this guideline does not absolve
physicians from the necessity of keeping up-to-date with the
most recent literature and does not replace decision-making with
the patient.
Targeted area of patient care
" Inpatient care, German-speaking countries, cross-sectoral care
" Outpatient care, German-speaking countries, cross-sectoral
care
This guideline targets patients aged 18 years and older with
symptomatic or asymptomatic female pelvic organ prolapse with
or without stress urinary incontinence.
User group/target audience
This guideline is aimed at gynecologists, coloproctologists and
physiotherapists. It additionally provides information for urolo-
gists and GPs.
Adoption and period of validity
This guideline is valid from May 1st, 2016 through to April 30th,
2019. Because of its specific contents, this period of validity isBaeßlonly an estimation. If important changes in the evidence should
occur, amendments to the guideline will be published by the
AWMF after a methodological validation even before the period
of validity has expired.III Methodology
The methodology used to compile this guideline was based on a
stratified classification system. The rules are prescribed by the
AWMF rulebook (version 1.0). Guidelines are differentiated into
lowest level (S1), intermediate level (S2e or S2k) and highest level
(S3).The lowest level is defined as a collection of recommenda-
tions for action compiled by a non-representative group of ex-
perts. In 2004 the S2 category was subdivided into 2 sublevels:
systematic evidence-based (S2e) and structurally consensus-
based (S2k). The highest level (S3) integrates both approaches.
This guideline corresponds to level: S2e
Literature search, inclusion and exclusion criteria
" An extensive literature search in MEDLINE, Embase, Cinahl, Pe-
dro and the Cochrane Register, in reference lists and among the
abstracts of the Annual Meetings of the International Conti-
nence Society (ICS) and the International Urogynecological As-
sociation (IUGA).
" Abstracts were included if they described randomized studies
which had been presented to and discussed by a panel of ex-
perts.
" Following the 2nd FDAwarning in July 2011 on the use of syn-
thetic meshes in vaginal prolapse surgery (http://www.fda.
gov/downloads/medicaldevices/safety/alertsandnotices/
ucm262760.pdf), the original plan to include literature up until
2011 was expanded. Publications up until 2014 were included.
" Search terms: pelvic organ prolapse, cystocele, rectocele, enter-
ocele, uterine prolapse AND therapy, pessary, pelvic floor exer-
cise, pelvic floor muscle training, surgery, repair, colporrhaphy,
sacrocolpopexy, sacral colpopexy, mesh, stress urinary inconti-
nence; ultrasound, ultrasonography, urodynamics; complica-
tions
" Inclusion criteria: original research published since 2008; fol-
low-up of at least 12 months to evaluate success rates; no time
limits for descriptions of perioperative complications.
" No limitations with respect to language.
" Definition of anatomical success following surgery: no prolapse
beyond stage 1 according to the IUGA/ICS prolapse quantifica-
tion system [1,2]. Stage 2 is considered an anatomical failure.
This corresponds approximately to Baden-Walker Grade 2, i.e.
“prolapse to the hymen”, while Grade 1 (“prolapse half-way to
thehymen”)would still be assessed as a success or as normal, as
long as the patient is asymptomatic [3].
Grading of evidence using Oxford
For the purposes of this guideline, evidence was classified (levels
1–5) in accordance with the classification system of the Oxford
Centre for Evidence-based Medicine in its 2009 version.
While the quality of the evidence (strength of evidence) is in-
tended as an indication of the robustness of the published data
and therefore of the degree of certainty/uncertainty associated
with the data, the level of recommendation expresses the result
of weighing up desired vs. unwanted consequences of alternative
approaches. For more information, please refer to the following
homepage: http://www.cebm.net/o?=1025.er K et al. Diagnosis and Therapy… Geburtsh Frauenheilk 2016; 76: 1287–1301
1290 GebFra ScienceRecommendation grading
The individual recommendations have been formulated in such a
way that they indicate the level of requirement for each recom-
mendation. There are three levels of requirement. The level of re-
quirement depends on the ratio between the benefits and the
disadvantages of alternative approaches. The terms “must/must
not” indicate a strong recommendation (high level of require-
ment), “should/should not” indicate a simple recommendation
(mid-level requirement), and “can” or “may”/“cannot” or “may
not” signify an open recommendation (limited level of require-
ment); if the recommendation is contraindicated, the physician
must make a decision after carefully weighing up the options.
This also applies to strong recommendations.Symbol Description of grade
of recommendation
Wording
A Strong recommendation, highly binding must/must not
B Recommendation, relatively binding should/should not
0 Open recommendation, not binding may/may notConflicts of interest
The conflict of interest statements of all guideline authors were
entered in the AWMF form, and the tabular list is included in the
long version of the guideline and in the guideline report (both in
German).IV Guideline
1 Introduction and definitions
Female pelvic organ prolapse or female genital prolapse is a com-
mon condition in women; the incidence of pelvic organ prolapse
is increasing due to the overall rise in life expectancy. Therapy
options consist of a number of conservative or surgical ap-
proaches. The aim of this guideline is to provide an evidence-
based description of the diagnosis and the conservative and sur-
gical therapy of female pelvic organ prolapse inwomen aged over
18 years. National and international socio-economic conditions
were also taken into consideration.
The recommendations for the diagnosis and treatment of female
pelvic organ prolapse are based on an extensive, systematic re-
view and evaluation of the recent literature which also took ac-
count of the experiences and specific conditions in Germany,
Austria and Switzerland. The guideline is an update of the guide-
line published in 2008 and has also included the warnings of the
American Food and Drug Administration (FDA), including the last
notification published in 2011 (http://www.fda.gov/medicalde-
vices/safety/alertsandnotices/publichealthnotifications/
ucm061976.htm) which led to substantive changes in prolapse
surgeries using mesh implants. General dissatisfaction with the
anatomical outcomes following standard prolapse surgery re-
sulted in a significant increase in the use of various biological
and synthetic implants (meshes). Following the second warning
by the FDA, some of industrially produced mesh kits which were
still available five years ago have since been withdrawn from the
market (e.g. Prolift®, Prosima®, Avaulta®, Perigee® in the USA, in
the meantime also Elevate®). The material properties (macro-
pores > 75 µm and lightweight ≤ 32 g/m2 meshes, no multifila-
ment absorbable or non-absorbable materials) of the new gener-
ation of meshes have been improved or amended, and the re-
quired apical fixation has now also been integrated.Baeßler K et al. Diagnosis and Therapy… Geburtsh Frauenheilk 2016; 76: 1287–130Female pelvic organ prolapse is often associated with stress uri-
nary incontinence. The symptoms of stress urinary incontinence
have been defined as a leakage or loss of urine in response to
physical activities such as coughing or lifting. If urine leakage
during coughing only occurs after repositioning of the prolapse
during clinical examination or after insertion of a pessary, it is re-
ferred to as occult stress incontinence. In addition to repair of the
prolapse, the simultaneous protection or recreation of conti-
nence is a special aspect which is also discussed in this guideline.
2 Diagnosis
2.1 Medical history
A standardized questionnaire should be used to record the pa-
tientʼs specific medical history of pelvic floor symptoms. It is rec-
ommended that validated questionnaires which also include an
assessment of the patientʼs quality of life should be used to assess
quality control and in all studies [1]. Validated pelvic floor ques-
tionnaires available in German include the questionnaire of the
International Consultation on Incontinence (ICI; www.iciq.net),
the German version of the Kingʼs Health Questionnaire [2], the
German version of the “urinary incontinence-specific measure
of quality of life” (I‑QOL) [3] and the German Pelvic Floor Ques-
tionnaire (German version of the Australian Pelvic Floor Ques-
tionnaire) [4], for which a validated post-therapeutic follow-up
module is also available [5].
2.2 Clinical examination
In addition to standard inspection of the external genitalia, as-
sessment of the prolapse is done using a split speculum, and the
evaluation must include coughing or pushing. The extent of pro-
lapse must be documented separately for the anterior (bladder,
anterior vaginalwalls), middle (cervix or uterine stump) and pos-
terior compartment. Quantification of the pelvic organ prolapse
using the ICS/IUGA standard terminology is internationally rec-
ommended [6,7]. This should then be followed by a cough stress
test carried out both without repositioning and after reposition-
ing of the prolapse, e.g. with a speculum, pessary, swab or digi-
tally, to detect clinical or occult stress urinary incontinence.
Further examination must consist of vaginal palpation of the pel-
vic floor and must include an assessment of pelvic floor contrac-
tility as well as rectal examination of patients with defecation
disorders and fecal incontinence.
Quick urine tests (dipstick test) are not sufficiently sensitive for
proper urine analysis; women with dysuria and a negative urine
dipstick test should be assessed using a urine culture test with an
antibiogram [8,9].
2.3 Imaging
2.3.1 Sonography
For an in-depth discussion, please refer to the detailed AWMF
guideline on the use of ultrasonography in urogynecology (only
available in German: Sonographie im Rahmen der urogynäkolo-
gischen Diagnostik, 015-055).
Assessment of residual urine with ultrasonography is part of the
standard examination for prolapse and bladder voiding disor-
ders.1
Evidence-based recommendation 2.E3
Level of evidence 3 Grade of recommendation 0
Perineal sonography can also be used as visual biofeedback to explain findings
to patients and show how pelvic floor contractions affect the bladder neck,
e.g. prior to coughing to reduce the prolapse [14–16].
Evidence-based recommendation 2.E4
Level of evidence 4 Grade of recommendation 0
Vaginal sonography can be used to shed light on a number of different
aspects:
" For a depiction of the uterus and the adnexa prior to surgery
" To exclude uterine pathologies prior to carrying out uterus-preserving
surgery
" To assess cervical length or the relationship between the uterine body and
the cervix: cervical elongation after uterus-preserving surgery can result in
persisting symptoms.
" To exclude extrauterine pelvic pathologies
Evidence-based recommendation 2.E7
Level of evidence 4 Grade of recommendation 0
If diffuse symptoms and findings such as bladder pain and hematuria are
also present, particularly if the patient has had a previous operation, cysto-
urethroscopy can help to excludemorphological causes such as bladder
tumors or stones, urethral stenosis, intravesical mesh erosion, or chronic
urothelial changes caused by interstitial cystitis [25–27].
Evidence-based recommendation 2.E8
Level of evidence 3 Grade of recommendation B
Cystourethroscopy is recommended at the end of prolapse surgery to exclude
intraoperative bladder and urethral injury and to establish ureter function.
Evidence-based recommendation 4.E1
Evidence-based recommendation 2.E1
Level of evidence 3 Grade of recommendation 0
Renal sonography to exclude urinary retention is particularly recommended
in patients with high-grade prolapse. The prevalence of hydronephrosis is
reported to be 5–17%, although this usually decreases following surgical
treatment [52–55].
Evidence-based recommendation 2.E2
Level of evidence 3 Grade of recommendation 0
Pelvic floor sonography can be a useful diagnostic tool in addition to vaginal
and rectal examination.
Biological meshes are not detectable sonographically [10]. The position,
mobility, folding and even tearing of the proximal anchor fixation of synthetic
meshes can be detected sonographically using a perineal, introital or endo-
vaginal approach [10–13].
1291Guideline2.3.2 MRI
As with defecography, dynamic MRI can be used to obtain images
of all three compartments at rest, during pressing, and during
contractions of the pelvic floor [17]. Dynamic MRI can be used
to visualize complex and/or recurrent prolapse conditions [18,
19] and is particularly suitable to assess internal rectal prolapse/
intussusception and rectal emptying or stool retention [20–22].Evidence-based recommendation 2.E5
Level of evidence 3 Grade of recommendation 0
Dynamic MRI can be useful to visualize complex conditions and symptoms.
Level of evidence 3 Grade of recommendation C
As prolapse regression without therapy has also been reported [28,29],
observation alone should also be listed as an option during the discussionwith
the patient.
Evidence-based recommendation 4.E2
Level of evidence 2 Grade of recommendation B2.4 Urodynamic examinationEvidence-based recommendation 2.E6
Level of evidence 3 Grade of recommendation 0
A systematic review of diagnostic tests showed that the patientʼs medical
history and a clinical stress test are good predictors of stress urinary inconti-
nence in urodynamic studies [23,24]. There are no data which confirm the
necessity of carrying out urodynamic studies prior to planned prolapse sur-
gery. Occult stress incontinence can also be detected by carrying out stress
test with a sufficiently full bladder after prolapse repositioning.
Baeßl2.5 Cystourethroscopy3 Patient Information
To enable patients tomake an informed decision, the information
given to patients should be well structured and should include,
where possible, the physicianʼs own data on the successes and
complications of interventions. The discussion with the patient
should include information about the patientʼs medical condi-
tion; observant, conservative and surgical treatment options
along with their anatomical and functional success rates; the ad-
vantages and disadvantages of mesh implants; complications and
their treatment options; the impact of therapy on the patientʼs
sexuality, bladder and bowel functions, and further surgical in-
terventions which could potentially be necessary (e.g. two-stage
stress urinary incontinence surgery).
4 Conservative Therapy
As many women are not aware of their pelvic organ prolapse,
surgery should only be carried out in symptomatic patients and
in patients who are bothered by the prolapse [28]. Conservative
options include pelvic floor rehabilitation, pessary therapy, clini-
cal observation, reduction of known risk factors such as obesity,
smoking and chronic constipation, digital support during defeca-
tion (pressure placed on the posterior vaginal wall or the peri-
neum).Systemic hormone replacement therapy is not beneficial for pelvic floor func-
tion and should not be explicitly prescribed to treat prolapse or incontinence
[30,31].
Evidence-based recommendation 4.E3
Level of evidence 2 Grade of recommendation B
The application of topical estrogen in the vagina is an established treatment
for vaginal dryness and irritation of the vagina (e.g., to treat symptoms of
atrophic vaginitis) [32,33] and is essential in pessary therapy to prevent local
lesions, bleeding, and necrosis [34,35].
er K et al. Diagnosis and Therapy… Geburtsh Frauenheilk 2016; 76: 1287–1301
Evidence-based recommendation 5.E1
Level of evidence 3 Grade of recommendation B
Simultaneous apical fixation appears to significantly reduce the risk of recur-
rence. The patient should be examined to determine whether concomitant
anterior andmiddle compartment prolapse is present, as anterior vaginal wall
repair could be performed concomitantly with apical fixation.
Evidence-based recommendation 5.E2
Level of evidence 3 Grade of recommendation 0
The risk of cystocele recurrence appears to be higher following anterior vagi-
nal wall repair in patients with levator defects (avulsions). Anterior mesh
placement can be considered in these patients [74].
Evidence-based recommendation 5.E3
Level of evidence 1a Grade of recommendation A
The use of syntheticmeshes in the anterior compartment further reduces the
1292 GebFra Science4.1 Pelvic floor muscle training
Several randomized studies have shown that targeted pelvic floor
muscle training can reduce the symptoms of prolapse, lower the
grade of prolapse, and prevent progression [36–41]. Studies have
also demonstrated an improvement in associated stress urinary
incontinence following pelvic floor muscle training [37,39,42].
It should be noted, however, that in these studies the correct pel-
vic floor contraction was determined by the physiotherapist by
means of palpation. This was then followed by individual and tar-
geted training of the pelvic floor musculature, which should not
be equated with the unspecific pelvic floor exercises often done
in Germany [43].
Five controlled randomized studies reported conflicting results
in response to the question whether perioperative pelvic floor
muscle training could improve functional outcome after prolapse
and/or incontinence surgery [44–47]: two of the studies [44,46]
reported improved incontinence and prolapse symptoms; how-
ever, three other studies [45,47,48] found no difference in out-
comes.
4.2 Pessary therapy
Pessaries can be successfully fitted in most women [49], with ob-
servational studies reporting success in around 50–100% of
cases; however, successful continuation of pessary therapy is
much lower, with a reported rate of 14–67% [50–59]. In addition
to prolapse symptoms, stress incontinence has been reported to
improve in 23–45% of cases; studies have also reported improve-
ments for overactive bladder, defecation disorders, sexual func-
tion and body image [52,60–63]. A prospective study found no
significant differences in terms of symptom scores between the
functional results for pessary therapy and those for surgical ther-
apy [64].
Indications for pessary therapy can include patient preference for
conservative treatment, temporary family planning when the pa-
tient intends to havemore children, and an increased risk of peri-
operative complications due to co-morbidities [65].
4.3 Recommendations for conservative therapyEvidence-based recommendation 4.E4
Level of evidence 1 Grade of recommendation B
Targeted pelvic floormuscle training (note: not gymnastical exercises) should
at least be offered to patients who have lower stages of prolapse (Stages I and
II) to reduce prolapse symptoms and concomitant stress urinary incontinence.
Evidence-based recommendation 4.E5
Level of evidence 3 Grade of recommendation 0
Accompanying perioperative pelvic floor rehabilitation may be considered;
however, the results reported in studies differ considerably.
Evidence-based recommendation 4.E6
Level of evidence 2 Grade of recommendation B
Pessary therapy is a good conservative option which should be offered to
patients. It is still not clear which pessary is most suitable for which type of
prolapse.
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5.1 Anterior colporrhapy or anterior vaginal wall
repairProlapse of the anterior vaginal wall is commonly associatedwith
an apical defect, so that surgical repair of the middle compart-
ment should be considered in these patients [66].
Success rates for anterior vaginal wall repair were reported in 22
randomized studies; they varied strongly and also depended on
the additional surgical procedures carried out concomitantly. Be-
cause of the different surgical techniques used in the studies, the
calculatedcumulativesuccess rateof63% formorethan1000wom-
enwho underwent surgery should be interpretedwith caution.
If surgery is performed concomitantly to support the apical (mid-
dle) compartment, the risk of recurrence decreases significantly
(OR: 0.68; 95% CI: 0.54–0.85).
The risk of recurrence appears to increase almost twofold in pa-
tients with levator defects (avulsion of the pubococcygeus
muscle from the pubic rami) [67–70].
5.2 Surgery using synthetic or biological implantsanatomical and subjective risk of prolapse recurrence but has no positive im-
pact on patientsʼ quality-of-life. However, de novo dyspareunia and re-opera-
tion formesh complications and urinary stress incontinence are more com-
mon compared to anterior vaginal wall repair. The decision making process
has to include information on rates of re-operation, chronic pain syndrome
and dyspareunia.
Evidence-based recommendation 5.E4
Level of evidence 3 Grade of recommendation 0
When placing a synthetic mesh in the anterior compartment, concomitant
apical mesh fixation or surgery to stabilize themiddle compartment can be
considered.
Evidence-based recommendation 5.E5
Level of evidence 1b Grade of recommendation B
Because the success rates for biological implants are not higher than the
success rates for anterior vaginal wall repair, biological implants should not
be used.
Evidence-based recommendation 5.E6
Level of evidence 3 Grade of recommendation 0
Women with levator defects (avulsion of the pubococcygeusmuscle from
the lower pubic rami) generally appear to have an increased riskof recurrence,
although the risk is lower following anterior synthetic mesh augmentation.
Anterior synthetic mesh augmentation can ormay therefore be considered in
these patients.
1
Evidence-based recommendation 5.E9
Level of evidence 1a Grade of recommendation A
The use of synthetic mesh in the anterior compartment reduces the anatomi-
cal and subjective rates of prolapse recurrence but without having an addi-
tional impact on patientsʼ quality of life. However, rates of de novo dyspareu-
nia and repeat surgery formesh complications and stress urinary incontinence
are higher compared to rates for anterior vaginal wall repair, indicating that
discussions with the patient must include information about repeat surgery,
chronic pain syndrome, and dyspareunia.
Evidence-based recommendation 5.E10
Level of evidence 3 Grade of recommendation 0
When placing a synthetic mesh in the anterior compartment it is worth con-
sidering concomitant apical mesh fixation or surgery to stabilize themiddle
compartment.
Evidence-based recommendation 5.E11
Level of evidence 1b Grade of recommendation B
Because the success rates for biological implants are not higher compared to
the rates for anterior vaginal wall repair, biological implants are not necessary.
Evidence-based recommendation 5.E12
Level of evidence 3 Grade of recommendation 0
Womenwith levator defects (avulsion of the pubococcygeusmuscle from the
pubic rami) generally appear to have a higher risk of recurrence, although the
risk is lower after anterior synthetic mesh augmentation, which is why this
approach should be considered for these patients.
Evidence-based recommendation 5.E13
Level of evidence 3 Grade of recommendation 0
A lackof adequate studiesmakes it impossible togivea clear recommendation
in support of paravaginal defect repair, irrespective of whether it is carried out
vaginally, abdominally or laparoscopically. This is because apical procedures
are usually carried out concomitantly and contribute to high success rates.
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79], anterior repair using a synthetic mesh (excluding Prolift®
and Perigee®) had a cumulative success rate of 93%; the cumula-
tive success rate of studies without apical fixation or without
standard apical surgery [80–89] was 83%. The cumulative rate of
mesh erosion was 8% (137/1740); the cumulative rate for chronic
pain and de novo dyspareunia was 7% (59/846).
In a retrospective analysis, women with levator avulsion had a
higher risk of cystocele recurrence even after placement of a syn-
thetic mesh [90].
A meta-analysis of randomized studies showed that the risk of
recurrence increased threefold when no synthetic mesh was
placed (RR: 3.5; 95% CI: 2.7–4.4). The success rate for anterior re-
pair was 52%, which increased to 86% (p < 0.001) with mesh aug-
mentation. Overall, repeat surgery for mesh complications, stress
urinary incontinence or recurrent prolapse was more common
following synthetic mesh implantation (RR: 0.58; 95% CI: 0.42–
0.81). Anterior repair reduced the risk of a repeat operation. After
anterior repair, the risk of de novo dyspareunia, which occurs
more frequently after transobturator synthetic mesh placement,
was also lower (RR: 0.46; 95% CI: 0.22–0.96). But this was not re-
flected in the validated sexual questionnaires (PISQ) which were
used in some studies.
Meta-analysis of randomized studies showed that Pelvicol® aug-
mentation did not offer better results than anterior repair (RR:
1.3; 95% CI: 0.8–2.2). Only one RCT [91] reported superior results
following Pelvicol® augmentation. This did not change, even
when the results of all studies which used any type of biological
implant were combined; the use of biological graft material did
not appear to improve success rates (RR: 1.34; 95% CI: 0.97–
1.86).
5.3 Vaginal, abdominal or laparoscopic repair
of paravaginal defects
Because studies differed considerably and the concomitant proce-
dures, which mainly affected the middle compartment and often
included apical fixation, also varied significantly, the reported
success rates of between 70 and 100% (vaginal repair: between
90 and 100%, cumulative success rate: 91% [92–97]; abdominal
repair: between 70 and 95%, cumulative success rate: 94% [92,
98–102]; laparoscopic repair: only one study, success rate: 80%
[103]) should be interpretedwith caution.
5.4 Recommendations for the anterior compartmentEvidence-based recommendation 5.E7
Level of evidence 3 Grade of recommendation B
If anterior vaginal wall repair is carried out, concomitant apical fixation ap-
pears to significantly decrease the riskof recurrence. Patients should therefore
be examined carefully to determinewhether theymay have both anterior and
middle compartment prolapse which would then allow anterior vaginal wall
repair to be combined with apical fixation.
Evidence-based recommendation 5.E8
Level of evidence 3 Grade of recommendation 0
The presence of a levator defect (avulsion) appears to increase the risk of
cystocele recurrence following anterior vaginal wall repair, and anterior mesh
placement can be considered in these patients [70].
Baeßl6 Surgical Therapy of Posterior Compartment
Prolapse
Rectoceles and posterior enteroceles can be the cause of both
prolapse symptoms and defecation disorders. Defecation disor-
ders often require manual transvaginal, transanal or perineal as-
sistance. It is important to determine preoperatively whether
these disorders are caused by a rectocele, an intussusception or
by descending perineum syndrome. Interdisciplinary collabora-
tion with coloproctologists can be useful, particularly if a defeca-
tion disorder is present without a visible rectocele.
6.1 Posterior colporrhapy or posterior vaginal wall
repair
The cumulative success rate for posterior vaginal wall repair us-
ing midline suturing of vaginal connective tissue (fascia) is signif-
icantly higher at 86% (cumulative success rate: 83/576) than the
70% reported for defect-specific repair (cumulative success rate:
82/271). The risk of recurrence is significantly reduced if midline
fascial suturing is done (OR: 0.4; 95% CI: 0.28–0.56), which is why
this technique should be the method of choice for primary recto-
cele repair.
The standard approach used to consist of the plication of the
levator ani, particularly of the distal levator, but this technique
did not reduce the rate of recurrence (45/220, cumulative success
rate 80%). Instead, use of an isolated midline fascial suture has
been found to yield better results (OR: 0.65; 95% CI: 0.44–0.98)
[104–106]. Approximation of the levator ani is not considereder K et al. Diagnosis and Therapy… Geburtsh Frauenheilk 2016; 76: 1287–1301
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with this method are not higher than those obtained using amid-
line fascial suture, and high rates of dyspareunia have been re-
ported with this technique.
Two randomized studies reported that transvaginal posterior
vaginal wall repair was superior to transanal rectocele repair in
terms of anatomical and functional success rates [104,107].
Transvaginal posterior vaginal wall repair is the method of choice
to treat symptomatic rectocele and should be used in preference
to transanal rectocele repair.
6.2 Surgery using synthetic or biological implants
The use of biological implants in the posterior compartment did
not show any benefits compared to posterior vaginal wall repair.
On the contrary, posterior vaginal wall repair was found to be su-
perior to the augmentation procedure with grafts, and meta-
analysis of all comparative randomized and non-randomized
studies showed that posterior vaginal wall repair halved the risk
of recurrence (RR: 0.58; 95% CI: 0.41–0.84). The use of xenografts
(biological implants) in the posterior compartment should be
avoided because their use offers no benefits.
There are no randomized studies on the use of non-absorbable
synthetic mesh in the posterior compartment. Although non-
controlled prospective and retrospective studies reported a low-
er rate of recurrence when synthetic mesh was used, there are
currently no comparative studies. There is therefore no reason
to use synthetic meshes routinely for primary vaginal wall repair
of the posterior compartment.
6.3 Recommendations for the posterior
compartmentEvidence-based recommendation 6.E1
Level of evidence 1 Grade of recommendation A
Posterior vaginal wall repair to treat a symptomatic rectocele should be
chosen in preference to transanal rectocele repair.
Evidence-based recommendation 6.E2
Level of evidence 2 Grade of recommendation B
Posterior vaginal wall repair usingmidline fascial suturing resulted in higher
rates of success compared to defect-specific fascial repair and this method
should be preferred for primary rectocele repair.
Evidence-based recommendation 6.E3
Level of evidence 3 Grade of recommendation 0
Plication of the levator ani is not necessary for posterior vaginal wall repair as it
does not result in higher success rates compared to amidline fascial repair and
the procedure is associated with high rates of dyspareunia.
Evidence-based recommendation 6.E4
Level of evidence 1b Grade of recommendation A
Xenografts (biological implants) should not be used for prolapse repair
in the posterior compartment because their use offers no benefits.
Evidence-based recommendation 6.E5
Level of evidence 3 Grade of recommendation 0
There are no randomized studies on the use of non-absorbable mesh in the
posterior compartment. Although non-controlled prospective and retrospec-
tive studies showed that synthetic mesh placement was associated with a
lower rate of recurrence, there are no comparative studies on this issue.
There is therefore currently no reason to use synthetic meshes routinely for
primary repair of the posterior compartment.
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The surgical repair of suspension defects in the middle compart-
ment (level 1 according to DeLancey [108]) is of special impor-
tance as this repair is often carried out in addition to repair of
the anterior or posterior compartment and is also as a stand-
alone procedure to treat uterine or vaginal vault prolapse.
7.1 Uterosacral ligament fixation/McCall technique/
Shull technique
A systematic review of transvaginal high fixation of the vaginal
vault to the uterosacral ligaments showed a cumulative apical
success rate of 98% (95% CI: 95.7–100), an anterior success rate
of 81% (95% CI: 67.5–94.9) and a posterior success rate of 87%
(95% CI: 80–94.9) [109]. Retrospective studies of laparoscopic
fixation of the vaginal vault to the uterosacral ligaments after
concomitant hysterectomy reported an apical failure rate of 11–
13% [110,111].
Vaginal suspension using the uterosacral ligaments is associated
with the risk of ureteral injury, ureter ligation and ureteral medial
deviation in around 6% (1–11%), and intraoperative cystoscopy is
therefore recommended.
7.2 Sacrospinous fixation
In a randomized study published in 2014, Barber et al. [48] re-
ported no significant anatomical or functional differences be-
tween vaginal fixation to the uterosacral ligaments or sacrospi-
nous fixation.
Recurrence is most common in the anterior compartment, with
reported rates of 5–39% (157/1036, 15%), and occurs less often
in the posterior compartment (5–12%, 32/442, 7%). Apical fixa-
tion is very effective with a cumulative success rate of 96% (rate
of recurrence: 0–14%, 45/1121 [4%]).
7.3 Abdominal, laparoscopic and robot-assisted
sacrocolpopexy
A systematic review by Nygaard et al. [112] reported apical suc-
cess rates of 78–100% for abdominal sacrocolpopexy and a cumu-
lative rate of re-operation for prolapse recurrence of 4.4%. In 23
studies, laparoscopic sacrocolpopexy had an equally high cumula-
tive success rate of 91% (number of failures: 215/2341).
In a randomized study, Maher et al. compared laparoscopic sac-
rocolpopexy including anterior and posterior polypropylene
mesh extension with the vaginal Prolift® mesh kit which has
since beenwithdrawn from themarket by its manufacturer (Ethi-
con®) and is no longer available [113]. While laparoscopic sacro-
colpopexy took longer (difference: + 52min [95% CI: 41.5–62.6]),
patients were discharged earlier from hospital and were able to
resume day-to-day activities more quickly. After two years, re-
currence across all compartments was significantly more com-
mon in the vaginal mesh group (57 vs. 23%) [113], as was the rate
of re-operations (22 vs. 5%, p = 0.006).
7.4 Vaginal high levator myorrhaphy and vaginal
fixation of the vaginal vault to the Iliococcygeus
fascia
In a randomized study, the apical success rate was 97% after leva-
tor myorrhaphy and 98% following uterosacral ligament fixation.
The rate of cystocele recurrence was relatively high at 29 and
35%, respectively [114]. There are only a few case series describ-
ing vaginal fixation to the fascia of the iliococcygeus muscle, with
apical success rates of 53, 83 and 96%.1
Evidence-based recommendation 7.E6
Level of evidence 2 Grade of recommendation B
Intraoperative cystoscopy is recommended for vaginal vault suspension to the
uterosacral ligaments because of the increased risk of injury to the ureter.
Evidence-based recommendation 7.E7
Level of evidence 2 Grade of recommendation B
Uterine preservation should be considered in patients with the appropriate
indications. Vaginal sacrospinous hysteropexy is a good option; there is not
yet enough long-term data available on sacrohysteropexy procedures with
mesh interposition or fixation to the uterosacral ligaments.
Evidence-based recommendation 7.E8
Level of evidence 3 Grade of recommendation 0
Vaginal high levator myorrhaphy and vaginal fixation of the vaginal vault to
the fascia of the iliococcygeusmuscle have not been studiedmuch and should
therefore only be carried out if specifically indicated or if there are no other
alternatives.
Evidence-based recommendation 7.E9
Level of evidence 3 Grade of recommendation 0
Colpocleisis can be considered in selected patients after carefully discussing
the procedure with patients.
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If the uterus is healthy with no history of previous disease and no
signs of clinical or sonographic uterine pathology, if the patient
wishes it, she should be offered a uterus-preserving procedure.
Options include vaginal sacrospinous hysteropexy, laparoscopic
or open sacrohysteropexy with mesh interposition, and fixation
of the uterus to the uterosacral ligaments. Please also refer to
the AWMF hysterectomy guideline (015-070).
Five studies directly compared vaginal hysterectomywith vaginal
vault fixation to the uterosacral ligaments and sacrospinous hys-
teropexy but found no significant differences (rates of recur-
rence: 8 vs. 4%).
7.6 Colpocleisis
Colpocleisis is considered a relatively quick procedure with few
complications and is predominantly offered to older womenwith
multiple morbidities who are no longer sexually active and no
longer wish to be sexually active. Recurrence following colpoclei-
sis is very rare; studies report an improvement in quality of life
and in bladder and bowel function but also that a small number
of women (< 5%) regretted the operation [115,116]. Crisp et al.
[117] reported in 2013 that 13.8% of 87 women regretted the
procedure.
7.7 Recommendations for the middle compartmentEvidence-based recommendation 7.E1
Level of evidence 2 Grade of recommendation A
There is good evidence showing that sacrospinous colpopexy, vaginal or
laparoscopic fixation to the uterosacral ligaments and open, laparoscopic or
robot-assisted sacrocolpopexy can all be used for the repair of middle com-
partment prolapse, with success rates of more than 90% reported in the liter-
ature. The final choice of proceduremust bemade together with the patient
andmust weigh up all the findings and symptoms, comorbidities, risk factors,
the potential benefit of a planned concomitant hysterectomy procedure,
the patientʼs own wishes, and the departmentʼs level of expertise.
Evidence-based recommendation 7.E2
Level of evidence 2 Grade of recommendation B
Abdominal sacrocolpopexy is a procedure which has been studied very ex-
tensively and for the longest period of time; it is currently themost effective
procedure. Laparoscopic sacrocolpopexy can also be considered by depart-
ments with the necessary experience in carrying out the procedure.
Evidence-based recommendation 7.E3
Level of evidence 2 Grade of recommendation B
Carrying out a hysterectomy concomitantly with sacrocolpopexy should be
avoided because of the increased risk of mesh erosion.
Evidence-based recommendation 7.E4
Level of evidence 1b Grade of recommendation B
Sacrocolpopexy and sacrospinous fixation procedures are approximately
equivalent but offer different benefits and have different disadvantages.
If there are no contraindications, sacrocolpopexy can be carried out in prefer-
ence to sacrospinous fixation.
Evidence-based recommendation 7.E5
Level of evidence 2 Grade of recommendation A
The use of absorbable or biological implants for fixation to the sacrum in
sacrocolpopexy is not recommended.
Baeßl8 Genital prolapse and stress urinary incontinence
A risk calculator to weigh up the risk of postoperative stress in-
continence was developed based on several models and studies
[118]. The risk calculator takes a number of factors into account
(www.r-calc.com/ExistingFormulas.aspx?filter=CCQHS).
8.1 Continent women with genital prolapse
A meta-analysis showed that, compared to transobturator mesh
procedures, anterior vaginal wall repair protected patients from
developing stress incontinence (RR: 0.64; 95% CI: 0.42–0.97)
[119]. However, one study evaluated the long-term data after
three years and no longer found any significant difference be-
tween the two procedures [72,120].
The CARE study [121] compared abdominal sacrocolpopexy in
preoperatively continent women with (n = 157) and without
(n = 165) concomitant Burch colposuspension. At two years post-
operatively, significantly fewer women in the Burch group were
incontinent. The study was therefore terminated ahead of sched-
ule and is underpowered.
8.2 Women with symptomatic stress urinary
incontinence and genital prolapse
The results of two randomized studies of women with stress in-
continence and cystocele who underwent anterior vaginal wall
repair showed that 48% (19/40) were continent postoperatively
[122,123]. The cumulative continence rate following transobtu-
rator mesh was 61% (81/132) [124–126]. However, after the ad-
ditional insertion of a suburethral tape, 235 out of 237 women
(99%) were continent postoperatively [87,127–129].
One randomized study investigated the question whether treat-
ment should be carried out as a one-stage or a two-stage proce-
dure; it was found that the treatment of stress incontinence was
equally successful, irrespective of whether the suburethral TVT
was inserted at the same time as the anterior vaginal wall repair
(83/87, 95%) or three months later (47/53, 89%; based on an on-
treatment analysis) [130]. However, 27/94 women (29%) were
continent following prolapse surgery alone and refused the
planned TVT procedure threemonths later [130].er K et al. Diagnosis and Therapy… Geburtsh Frauenheilk 2016; 76: 1287–1301
Evidence-based recommendation 9.E2
Level of evidence 2 Grade of recommendation B
The preoperative placement of ureteral stents can be dispensed with as
it does not reduce ureteral injuries.
Evidence-based recommendation 9.E3
Level of evidence 3 Grade of recommendation 0
Postoperative application of topical estrogen can improve vaginal flora and
reduce granulation tissue; there is no evidence that it reduces the rates of
mesh erosion.
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and genital prolapse
Three randomized studies reported that suburethral tape inser-
tion concomitantly with prolapse repair (especially anterior vagi-
nal wall repair) significantly reduced stress incontinence rates
(21/116, 18% vs. 64/125, 51%) [131–133]. A meta-analysis of
these studies showed a decrease by almost 50% (RR: 0.54; 95%
CI: 0.41–0.72).
8.4 Recommendations for prolapse and urinary
stress incontinenceEvidence-based recommendation 8.E1
Level of evidence 2 Grade of recommendation B
In preoperatively continent womenwithgenital prolapse, anterior vaginalwall
repair is preferable to transobturatormesh placement to reduce the rate
of de novo stress incontinence. The higher rate of recurrence associated with
anterior vaginal wall repair compared to transobturatormesh placement
should be take into consideration when discussing potential procedures with
the patient.
Evidence-based recommendation 8.E2
Level of evidence 2 Grade of recommendation B
A concomitant Burch colposuspension can be additionally offered to patients
undergoing sacrocolpopexy as a prophylactic measure against postoperative
stress incontinence.
Evidence-based recommendation 8.E3
Level of evidence 1 a Grade of recommendation A
Patients with occult stress incontinence should be informed about the
possibility of undergoing concomitant suburethral tape insertion during
vaginal prolapse surgery.
Evidence-based recommendation 8.E4
Level of evidence 2 Grade of recommendation A
Suburethral tape insertion can also be performed as a two-stage procedure,
e.g. at threemonths after prolapse surgery.
Evidence-based recommendation 8.E5
Level of evidence 2 Grade of recommendation B
Women with symptomatic stress incontinence and prolapse can be offered
simultaneous surgery to treat stress incontinence.
Evidence-based recommendation 8.E6
Level of evidence 2 Grade of recommendation 0
Suburethral tape insertion can be carried out in preference to Burch
colposuspension when treating patients with sacrocolpopexy.9 Perioperative Management
There is very little evidence-based literature on the perioperative
management of gynecological or urogynecological patients.
Please refer to the appropriate AWMF guidelines for the periop-
erative administration of antibiotics, thrombosis prophylaxis and
patient positioning (029-022, 003-001, 015-077).Evidence-based recommendation 9.E1
Level of evidence 2 Grade of recommendation 0
Preoperative and/or postoperative pelvic floor muscle training may be pre-
scribed; however, there is no clear evidence that this will improve inconti-
nence and prolapse compared to pelvic floor surgery without perioperative
pelvic floor muscle training.
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10.1 Mesh erosion, extrusion, shrinkage
The rates of vaginal erosion following abdominal sacrocolpopexy
are between 0 and 10% after 7 years [134]. The reported rates fol-
lowing vaginal mesh implantationwere between 0 and 30% [135,
136]; in the analysis carried out for this guideline the calculated
rate was 8% (137/1740). Risk factors for erosion were concomi-
tant hysterectomy procedure, smoking, and the use of
polytetrafluoroethylene mesh [134] as well as higher BMI
> 30 kg/m2 (OR: 10) [137]. The colpotomy required for mesh
placement should be as short as possible [138]. Smoking in-
creases the risk of vaginal mesh erosion in both vaginal and ab-
dominal mesh implantations (OR: 4.2; 95% CI: 2.5–7.0) [139–
142].
Treatment depends on the extent of erosion and the presence or
absence of co-infections. Topical application of estrogen is rec-
ommended but is often not enough, and partial excision of the
mesh is then necessary [143]. The cumulative success rate for
topical estrogen application to treat vaginal erosion is 24% (33/
139) [142,144–149].
10.2 Organ injuries
There are few reports in the literature on injuries to the bladder,
urethra and ureter. Late visceral mesh erosion is rare, and the on-
ly literature to date consists of individual case reports.
Mesh implantation is still possible after intraoperative bladder
injury and repair immediately intraoperatively. However,
placement of a synthetic mesh should be avoided if there is in-
advertent rectotomy intraoperatively.
10.3 Sexual dysfunction
Prolapse surgery can improve dyspareunia but it can also be the
cause of dyspareunia arising from scarring, overcorrection, he-
matoma formation, or nerve irritation or injury. Chronic pain
and dyspareunia have been reported in 3–13% of cases, particu-
larly after vaginal mesh placement [135,136]. If the cause of dis-
comfort is found to be “tension” of the mesh or its fixation arms,
treatment options include mobilization of the mesh, incision of
the mesh or of its fixation arms, and excision of part of the mesh
[144,150]. Complete excision of the mesh is rarely indicated. Sur-
gical procedures to partially or completely excise the mesh can be
difficult; surgery may not always eliminate or reduce patient dis-
comfort and can lead to further complications [150–152]. This is
a particular problem of mesh-assisted surgical procedures, and it
is therefore particularly important to provide the patient with
detailed information on the risks involved.1
1297Guideline10.4 Recommendations for the management
of complicationsEvidence-based recommendation 10.E1
Level of evidence 3 Grade of recommendation B
During the discussion with their physician, patients who smoke should be in-
formed about the increased risk of mesh erosion after plannedmesh implan-
tation, and the physician should recommend that the patient stops smoking.
Evidence-based recommendation 10.E2
Level of evidence 3 Grade of recommendation B
Initial treatment of vaginal mesh erosion can consist of the application of
topical estriol or estradiol. If the patient does not respond to treatment, local
excision of the exposedmesh should be performed using tension-free vaginal
suturing.
Evidence-based recommendation 10.E3
Level of evidence 3 Grade of recommendation B
Complete excision of themesh, particularly of multifilament mesh, should be
aimed for in patients with chronic mesh infection or recurrent abscess.
Evidence-based recommendation 10.E4
Level of evidence 3 Grade of recommendation B
Because of the high number of associated complications, multifilamentmesh
should not be used for prolapse repair.
Evidence-based recommendation 10.E5
Level of evidence 3 Grade of recommendation 0
If the mesh arms or the synthetic mesh are identified as the cause of chronic
pain syndrome, partial or complete mesh excision or division of fixation arms
from the central graft can be considered.
Evidence-based recommendation 10.E6
Level of evidence 4 Grade of recommendation 0
Plannedmesh placement is still possible despite inadvertent injury to the
bladder if the bladder is treated immediately intraoperatively; however,
mesh placement should be avoided after inadvertent injury to the rectum.11 Summary
An in-depth discussionwith the patient about expectant, conser-
vative and surgical management options to treat prolapse is nec-
essary. Conservative options include targeted pelvic floor muscle
training for patients with low grade prolapse, as this can reduce
the extent of prolapse and incontinence symptoms, and pessary
therapy. A pessary can usually be successfully fitted in most pa-
tients and is a low-risk option.
The individual surgical procedure should be chosen in a shared
decision making process together with the patient. Current stud-
ies and evidence show that there is a wide range of surgical pro-
cedures which involve either autologous tissue or synthetic mesh
augmentation. Because of the higher rate of complications after
vaginal mesh implants, this should only be used when specifi-
cally indicated, after the patient has been informed in detail and
the benefits and disadvantages carefully weighed up. At present,
it is not possible to clearly define the indications. Possible indica-
tions include recurrent or total prolapse combined with risk fac-
tors such as obesity, chronic obstructive pulmonary disease and
indications of generalized connective tissue weakness. Patients
with levator defects (levator avulsions) have a higher risk of ante-
rior compartment prolapse recurrence, and placement of a syn-
thetic mesh appears to reduce this risk. Mesh placement should
be considered for patients with high grade prolapse, prolapse re-Baeßlcurrence, levator avulsions and for patients who are anxious
about anatomical correction.
The patient must be informed in detail about the success rates of
individual procedures with and without mesh placement, about
the treatment alternatives and possible complications. The pa-
tient should be informed about the lack of studies on long-term
outcomes after vaginal mesh placement.
Regular postoperative documentation of pelvic floor dysfunction
and of patientsʼ quality of life is recommended to evaluate the
surgical technique and the indications and adapt them where
necessary. New surgical procedures with or without implants
should only be introduced in the context of clinical trials. In addi-
tion to anatomical outcomes, studies should particularly focus on
the prospective evaluation of pelvic floor function and on pa-
tientsʼ quality of life.
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